Aspen MSD buy
July 1, 2013
THE Aspen Group has purchased
MSD’s Netherlands manufacturing
business for approx US$1b.
Stephen Saad‚ Aspen’s chief
executive‚ said: “One of Aspen’s
primary strategic intents is to
globalise its business‚ increase its
representation across a number of
additional territories and provide
support to its growing global
presence with a differentiated
pipeline of products”.
Products covered include
11 brands including Ovestin,
Sustanon, Metrigen, Orgaran,
Decadron, Oradexon, Metricorten,
Meticorelone, Deca Durabolin,
Thyrax, Strumazol, Gracial, Novial
and Benutrex.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 13